Valuation: Berkley Renewables Inc.

Market Cap 364K 319K 293K 273K 518K 34.7M 525K 3.51M 1.37M 17.05M 1.37M 1.34M 58.77M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.48M 4.12M 3.84M 7.28M 488M 7.39M 49.44M 19.22M 240M 19.24M 18.83M 827M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 19/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 16/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+1.46%-1.16%+11.80%+0.68% 128B
+0.82%+1.18%+29.50%+53.63% 83.02B
+1.70%-1.37%+6.20%+14.43% 69.66B
+2.02%-2.16%+11.67%-16.95% 48.65B
+0.05%-4.37%+22.10%+31.73% 48.4B
+0.55%-4.12%+21.79%-16.56% 46.68B
+0.86%+0.26%+84.03%+54.31% 46.46B
+1.58%+1.22%+18.60%-17.94% 36.75B
+0.25%-0.17%-4.88%+30.22% 32.91B
Average +0.93%-1.48%+22.31%+14.84% 54.01B
Weighted average by Cap. +1.12%-1.63%+21.23%+15.44%

Financials

2016 2017
Net sales 1.03M 904K 831K 774K 1.47M 98.46M 1.49M 9.97M 3.88M 48.4M 3.88M 3.8M 167M 1.72M 1.51M 1.39M 1.29M 2.45M 164M 2.49M 16.64M 6.47M 80.72M 6.47M 6.34M 278M
Net income 173K 151K 139K 129K 245K 16.44M 249K 1.67M 648K 8.08M 648K 634K 27.85M -631K -551K -507K -472K -896K -60.03M -909K -6.08M -2.36M -29.51M -2.37M -2.32M -102M
Net Debt 2.92M 2.55M 2.34M 2.18M 4.14M 278M 4.21M 28.13M 10.94M 137M 10.95M 10.71M 470M 4.76M 4.16M 3.83M 3.57M 6.76M 453M 6.87M 45.92M 17.85M 223M 17.87M 17.49M 768M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-